Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc.

PLX
Protalix BioTherapeutics, Inc.US flagNew York Stock Exchange Arca
2.36
USD
-0.05
- -
190.15MMarket Cap

Protalix BioTherapeutics, Inc. (PLX) Stock Split History

Learn about Protalix BioTherapeutics, Inc.'s most recent 1-for-10 basis stock split on December 20, 2019. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Protalix BioTherapeutics, Inc.'s most recent stock split

Split Date: 2019-12-20
Split Ratio: 1:10
Price Before Split: $0.26
Price After Split: $0.03

Developer API

Get PLX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/PLX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Protalix BioTherapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2019-12-201:10Yes$0.26$0.03
2007-01-031:10Yes$2.71$0.27

About Protalix BioTherapeutics, Inc.

Company overview and industry information

Protalix BioTherapeutics, Inc. (PLX) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Protalix BioTherapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.